Global Nuclear Magnetic Resonance (NMR) Spectrometer Market 2018-2022

Detailed TOC of Global Nuclear Magnetic Resonance (NMR) Spectrometer Market 2018-2022

Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY END-USERS
• Overview
• Comparison by end-users
• Pharmaceutical and biotechnology industry
• Chemical and petrochemical industry
• Others
• Market opportunity by end-user
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increase in use of hyphenated technology
• Growing investments in biomedical industry
• Increasing demand for instruments for personalized medicine
• Increasing demand for portable instruments
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies
• Bruker
• JEOL
• Merck Group
• Thermo Fisher Scientific
• Other prominent vendors
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global molecular spectrometer market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global NMR spectrometer market: Segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global NMR spectrometer market 2017-2022 ($ millions)
Exhibit 09: Global NMR spectrometer market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Market condition: Five forces 2022
Exhibit 19: Global NMR spectrometer market: Segmentation by end-users 2017-2022 (% share)
Exhibit 20: Comparison by end-users
Exhibit 21: Global NMR spectrometer market by pharmaceutical and biotechnology industry 2017-2022 ($ millions)
Exhibit 22: Global NMR spectrometer market by pharmaceutical and biotechnology industry: Year-over-year growth 2018-2022 (%)
Exhibit 23: Global NMR spectrometer market by chemical and petrochemical industry 2017-2022 ($ millions)
Exhibit 24: Global NMR spectrometer market by chemical and petrochemical industry: Year-over-year growth 2018-2022 (%)
Exhibit 25: Global NMR spectrometer market by others 2017-2022 ($ millions)
Exhibit 26: Global NMR spectrometer market by others: Year-over-year growth 2018-2022 (%)
Exhibit 27: Market opportunity by end-users
Exhibit 28: Customer landscape
Exhibit 29: Global NMR spectrometer market: Segmentation by geography 2017-2022 (% share)
Exhibit 30: Regional comparison
Exhibit 31: NMR spectrometer market in Americas 2017-2022 ($ millions)
Exhibit 32: NMR spectrometer market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 33: Top-three countries in Americas
Exhibit 34: NMR spectrometer market in EMEA 2017-2022 ($ millions)
Exhibit 35: NMR spectrometer market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 36: Top-three countries in EMEA
Exhibit 37: NMR spectrometer market in APAC 2017-2022 ($ millions)
Exhibit 38: NMR spectrometer market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 39: Top-three countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Pharmaceutical R&D spending in US and Europe
Exhibit 42: Region-wise growth of R&D spending in biomedical industry 2010-2015
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Agilent Technologies: Overview
Exhibit 49: Agilent Technologies: Business segments
Exhibit 50: Agilent Technologies: Organizational developments
Exhibit 51: Agilent Technologies: Geographic focus
Exhibit 52: Agilent Technologies: Segment focus
Exhibit 53: Agilent Technologies: Key offerings
Exhibit 54: Bruker: Overview
Exhibit 55: Bruker: Business segments
Exhibit 56: Bruker: Organizational developments
Exhibit 57: Bruker: Geographic focus
Exhibit 58: Bruker: Segment focus
Exhibit 59: Bruker: Key offerings
Exhibit 60: JEOL: Overview
Exhibit 61: JEOL: Business segments
Exhibit 62: JEOL: Organizational developments
Exhibit 63: JEOL: Geographic focus
Exhibit 64: JEOL: Segment focus
Exhibit 65: JEOL: Key offerings
Exhibit 66: Merck Group: Overview
Exhibit 67: Merck Group: Business segments
Exhibit 68: Merck Group: Organizational developments
Exhibit 69: Merck Group: Geographic focus
Exhibit 70: Merck Group: Segment focus
Exhibit 71: Merck Group: Key offerings
Exhibit 72: Thermo Fisher Scientific: Overview
Exhibit 73: Thermo Fisher Scientific: Business segments
Exhibit 74: Thermo Fisher Scientific: Organizational developments
Exhibit 75: Thermo Fisher Scientific: Geographic focus
Exhibit 76: Thermo Fisher Scientific: Segment focus
Exhibit 77: Thermo Fisher Scientific: Key offerings